These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19441487)

  • 21. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
    Wang F; Yang Y; Ju X; Udenigwe CC; He R
    J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Chemical Conjugation of l-Leucine to Chitosan on Dispersibility and Controlled Release of Drug from a Nanoparticulate Dry Powder Inhaler Formulation.
    Muhsin MD; George G; Beagley K; Ferro V; Wang H; Islam N
    Mol Pharm; 2016 May; 13(5):1455-66. PubMed ID: 26998555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug.
    Wang W; Chen S; Zhang L; Wu X; Wang J; Chen JF; Le Y
    Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():514-20. PubMed ID: 25492016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances.
    Desai KG
    Crit Rev Ther Drug Carrier Syst; 2016; 33(2):107-58. PubMed ID: 27651100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and evaluation of pH-sensitive sodium alginate/chitosan microparticles containing the antituberculosis drug rifampicin.
    Lacerda L; Parize AL; Fávere V; Laranjeira MC; Stulzer HK
    Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():161-7. PubMed ID: 24863212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quaternized chitosan-organic rectorite intercalated composites based nanoparticles for protein controlled release.
    Xu R; Xin S; Zhou X; Li W; Cao F; Feng X; Deng H
    Int J Pharm; 2012 Nov; 438(1-2):258-65. PubMed ID: 22982258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and characterization of chitosan-based pH-sensitive semi-interpenetrating network microspheres for controlled release of diclofenac sodium.
    Al-Kahtani Ahmed A; Bhojya Naik HS; Sherigara BS
    Carbohydr Res; 2009 Mar; 344(5):699-706. PubMed ID: 19246032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin.
    He Z; Santos JL; Tian H; Huang H; Hu Y; Liu L; Leong KW; Chen Y; Mao HQ
    Biomaterials; 2017 Jun; 130():28-41. PubMed ID: 28359018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods.
    Cerchiara T; Abruzzo A; di Cagno M; Bigucci F; Bauer-Brandl A; Parolin C; Vitali B; Gallucci MC; Luppi B
    Eur J Pharm Biopharm; 2015 May; 92():112-9. PubMed ID: 25769679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled and extended drug release behavior of chitosan-based nanoparticle carrier.
    Yuan Q; Shah J; Hein S; Misra RD
    Acta Biomater; 2010 Mar; 6(3):1140-8. PubMed ID: 19699817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
    Pawar H; Douroumis D; Boateng JS
    Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-assembled polymeric nanoparticle of PEGylated chitosan-ceramide conjugate for systemic delivery of paclitaxel.
    Battogtokh G; Ko YT
    J Drug Target; 2014 Nov; 22(9):813-21. PubMed ID: 24964055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterization of new insulin containing polysaccharide nanoparticles.
    Sarmento B; Ribeiro A; Veiga F; Ferreira D
    Colloids Surf B Biointerfaces; 2006 Dec; 53(2):193-202. PubMed ID: 17049214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release.
    Mazzarino L; Borsali R; Lemos-Senna E
    J Pharm Sci; 2014 Nov; 103(11):3764-3771. PubMed ID: 25187001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a gallic acid-loaded chitosan and polyvinyl alcohol hydrogel composite: Release characteristics and antioxidant activity.
    Thanyacharoen T; Chuysinuan P; Techasakul S; Nooeaid P; Ummartyotin S
    Int J Biol Macromol; 2018 Feb; 107(Pt A):363-370. PubMed ID: 28870747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation, characterization, and drug release in vitro of chitosan-glycyrrhetic acid nanoparticles.
    Zheng Y; Wu Y; Yang W; Wang C; Fu S; Shen X
    J Pharm Sci; 2006 Jan; 95(1):181-91. PubMed ID: 16315245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
    Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W
    Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug release behavior of chitosan-montmorillonite nanocomposite hydrogels following electrostimulation.
    Liu KH; Liu TY; Chen SY; Liu DM
    Acta Biomater; 2008 Jul; 4(4):1038-45. PubMed ID: 18337198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.